Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac 2% spray for acute local musculoskeletal pain
2005-000682-19Phase 3Active
- Sponsor
- FARMALIDER, S.A.
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute musculoskeletal pain, sprain and muscle strain comparing Diclofenac Farmalider 2% spray with Placebo (2 arms). Primary endpoint: Change in pain intensity on movement. Started Apr 2006; status: active.
02
Drugs
diclofenac
03
Conditions
acute musculoskeletal painsprainmuscle strain
Beyond the preview
Go deeper on 2005-000682-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000682-19.